title: Companies go toe to toe, as topical treatments for nail fungus bloom.
authors.forename: Cassandra
authors.initials: C
authors.lastname: Willyard
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence / Q000379:methods* / Q000639:trends; D025141:Drug Resistance, Fungal / Q000502:physiology; D005533:Foot Dermatoses / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D006801:Humans; D053685:Laser Therapy / Q000191:economics; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D014009:Onychomycosis / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D000077291:Terbinafine; D016896:Treatment Outcome; D014481:United States
chemical_list: D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine